# ACETYLCYSTEINE
> **ANDA205643** · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2023-11-01
## Drug
- **FDA Application Number:** ANDA205643
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETYLCYSTEINE
- **Generic name:** Acetylcysteine
- **Active ingredients:** ACETYLCYSTEINE
- **Dosage form:** SOLUTION
- **Route:** INHALATION, ORAL
- **Marketing status:** Discontinued
- **Sponsor:** EXELA PHARMA
- **First approval:** 2023-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205643)
---
*MORVS · CC0 1.0*